Two-Headed PROTAC: An Effective New Tool for Targeted Protein Degradation

被引:43
作者
Cyrus, Kedra [1 ]
Wehenkel, Marie [1 ]
Choi, Eun-Young [2 ]
Swanson, Hollie [2 ]
Kim, Kyung-Bo [1 ]
机构
[1] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA
关键词
estrogen receptor; ligases; PROTAC; proteomics; ubiquitin-proteasome pathway; ARYL-HYDROCARBON RECEPTOR; CHIMERIC MOLECULES; CHEMICAL GENETICS; UBIQUITINATION; BINDING; SCF;
D O I
10.1002/cbic.201000222
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Better than one: A novel class of PROTAC that recruits target protein for ubiquitination and subsequent degradation by the proteasome has been successfully synthesized and tested for its activity to degrade a target protein. © 2010 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码:1531 / 1534
页数:4
相关论文
共 21 条
  • [11] Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
    Sakamoto, KM
    Kim, KB
    Kumagai, A
    Mercurio, F
    Crews, CM
    Deshaies, RJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) : 8554 - 8559
  • [12] Chemical genetic control of protein levels: Selective in vivo targeted degradation
    Schneekloth, JS
    Fonseca, FN
    Koldobskiy, M
    Mandal, A
    Deshaies, R
    Sakamoto, K
    Crews, CM
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (12) : 3748 - 3754
  • [13] Chemical genetics resulting from a passion for synthetic organic chemistry
    Schreiber, SL
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (08) : 1127 - 1152
  • [14] Total synthesis of the potent proteasome inhibitor epoxomicin: A useful tool for understanding proteasome biology
    Sin, N
    Kim, KB
    Elofsson, M
    Meng, LH
    Auth, H
    Kwok, BHB
    Crews, CM
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (15) : 2283 - 2288
  • [15] F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex
    Skowyra, D
    Craig, KL
    Tyers, M
    Elledge, SJ
    Harper, JW
    [J]. CELL, 1997, 91 (02) : 209 - 219
  • [16] From knowing to controlling: A path from Genomics to drugs using small molecule probes
    Strausberg, RL
    Schreiber, SL
    [J]. SCIENCE, 2003, 300 (5617) : 294 - 295
  • [17] Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain
    Verma, R
    Peters, NR
    D'Onofrio, M
    Tochtrop, GP
    Sakamoto, KM
    Varadan, R
    Zhang, MS
    Coffino, P
    Fushman, D
    Deshaies, RJ
    King, RW
    [J]. SCIENCE, 2004, 306 (5693) : 117 - 120
  • [18] Zhang D, 2004, COMB CHEM HIGH T SCR, V7, P689
  • [19] Degradation of target protein in living cells by small-molecule proteolysis inducer
    Zhang, D
    Baek, SH
    Ho, A
    Kim, K
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (03) : 645 - 648
  • [20] Flavonoids as aryl hydrocarbon receptor agonists/antagonists: Effects of structure and cell context
    Zhang, S
    Qin, CH
    Safe, SH
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2003, 111 (16) : 1877 - 1882